Lessons learned from BRCA1 and BRCA2

被引:131
|
作者
Zheng, L [1 ]
Li, S [1 ]
Boyer, TG [1 ]
Lee, WH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA
基金
美国国家卫生研究院;
关键词
BRCA1; BRCA2; breast cancer; tumor suppressor; transcription regulation; DNA damage repair;
D O I
10.1038/sj.onc.1203968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse models established from conditional expression of mutant Brca1 alleles develop mammary gland tumors, providing compelling evidence that BRCA1 functions as a breast cancer suppressor. Human cancer cells and mouse cells deficient in BRCA1 or BRCA2 exhibit radiation hypersensitivity and chromosomal abnormalities, thus revealing a potential role for both BRCA1 and BRCA2 in the maintenance of genetic stability through participation in the cellular response to DIVA damage. Functional analyses of the BRCA1 and BRCA2 gene products have established their dual participation in transcription regulation and DNA damage repair. Potential insight into the molecular basis for these functions of BRCA1 and BRCA2 has been provided by studies that implicate these two tumor suppressors in both the maintenance of genetic stability and the regulation of cell growth and differentiation.
引用
收藏
页码:6159 / 6175
页数:17
相关论文
共 50 条
  • [21] BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela
    Lara, Karlena
    Consigliere, Nigmet
    Perez, Jorge
    Porco, Antonietta
    BIOLOGICAL RESEARCH, 2012, 45 (02) : 117 - 130
  • [22] BRCA1 and BRCA2 families and the risk of skin cancer
    Ginsburg, Ophira M.
    Kim-Sing, Charmaine
    Foulkes, William D.
    Ghadirian, Parviz
    Lynch, Henry T.
    Sun, Ping
    Narod, Steven A.
    FAMILIAL CANCER, 2010, 9 (04) : 489 - 493
  • [23] BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
    British Journal of Cancer, 2003, 88 : 1256 - 1262
  • [24] Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
    Venkitaraman, Ashok R.
    SCIENCE, 2014, 343 (6178) : 1470 - 1475
  • [25] Clinical management of BRCA1 and BRCA2 mutation carriers
    Domchek, S. M.
    Weber, B. L.
    ONCOGENE, 2006, 25 (43) : 5825 - 5831
  • [26] BRCA1 and BRCA2 in Indian Breast Cancer Patients
    Saxena, Sunita
    Szabo, Csilla I.
    Chopin, Sandrine
    Barjhoux, Laure
    Sinilnikova, Olga
    Lenoir, Gilbert
    Goldgar, David E.
    Bhatanager, Dinesh
    HUMAN MUTATION, 2002, 20 (06) : 473 - 474
  • [27] BRCA1 and BRCA2 -: breast cancer susceptibility genes
    Hofmann, W
    Schlag, PM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (09) : 487 - 496
  • [28] A family with three germline mutations in BRCA1 and BRCA2
    Liede, A
    Metcalfe, K
    Offit, K
    Brown, K
    Miller, S
    Narod, SA
    Moslehi, R
    CLINICAL GENETICS, 1998, 54 (03) : 215 - 218
  • [29] Management Updates for Women with a BRCA1 or BRCA2 Mutation
    Rachel Nusbaum
    Claudine Isaacs
    Molecular Diagnosis & Therapy, 2007, 11 : 133 - 144
  • [30] BRCA1 and BRCA2– breast cancer susceptibility genes
    W. Hofmann
    P. M. Schlag
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 487 - 496